Trial intelligence / Profile preview

Citalopram for Functional Abdominal Pain in Children

NCT00962039Phase 3Completed

Start
Jul 2004
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in functional abdominal pain (FAP) comparing Citalopram with Placebo (2 arms). Primary endpoints: Clinical Global Impression Scale - Improvement at 8 weeks, Clinical Global Impression Scale - Severity at 8 weeks and 1 more. Started Jul 2004; status: completed.

02

Drugs

citalopram
03

Conditions

functional abdominal pain (FAP)

Beyond the preview

Go deeper on NCT00962039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00962039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call